Anna Berkenblit – Biography
Last update: May 21, 2026Executive profile
Anna was Sr VP Head of Clinical Development for H3 Biomedicine. Anna served as Chief Medical Officer at Surrozen.
Anna Berkenblit is currentlyDirector at Nested Therapeutics - View - Nested Therapeutics org chart
Director at Surrozen - View - Surrozen org chart
Director at TORL BioTherapeutics - View - TORL BioTherapeutics org chart
Create your alert
to follow the career of Anna Berkenblit.
Education
Anna Berkenblit has a Bachelor of Science in Molecular Biochemistry and Biophysic from Yale University and a Doctor of Medicine from Harvard Medical School.
They have also studied at Yale University :
Find more alumni from Yale University
They have also studied at Harvard Medical School :
Find more alumni from Harvard Medical School
More about Anna Berkenblit
Do you need to know more about Anna Berkenblit? More results.
Participate
Social media
- Anna Berkenblit on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Anna Berkenblit
The colleagues of Anna Berkenblit
Company Colleagues
- At Nested Therapeutics, Anna Berkenblit has 13 colleagues including Darrin Miles (CEO), Josh Richardson (Director)…
- At Surrozen, Anna Berkenblit has 23 colleagues including Craig Parker (CEO & Director), Mary Haak-Frendscho (Director)…
- At TORL BioTherapeutics, Anna Berkenblit has 25 colleagues including Aran Maree (CEO & Director), Skip Burris (Director)…
Industry Colleagues
- In the Biotechnology industry, Anna Berkenblit has 35,899 colleagues in 2,414 companies located in 43 countries. 17,031 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Anna Berkenblit.
Get in Touch
Here are a few tips for establishing great contacts.
and ask for Anna Berkenblit.
